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Acute kidney injury (AKI) is associated with significant morbidity and mortality in hypertensive surroundings. We investigated
superoxide radical molecules influence on systemic haemodynamic and kidney function in spontaneously hypertensive rats (SHR)
with induced postischemic AKI. Experiment was performed in anesthetized adult male SHR. The right kidney was removed, and
left renal artery was subjected to ischemia by clamping for 40 minutes. The treated group received synthetic superoxide dismutase
mimetic TEMPOL in the femoral vein 5 minutes before, during, and 175 minutes after the period of reperfusion, while the control
AKI group received the vehicle via the same route. All parameters were measured 24 h after renal reperfusion. TEMPOL treatment
significantly decreased mean arterial pressure and total peripheral resistance (𝑃 < 0.05) compared to AKI control. It also increased
cardiac output and catalase activity (𝑃 < 0.05). Lipid peroxidation and renal vascular resistance were decreased in TEMPOL
(𝑃 < 0.05). Plasma creatinine and kidney morphological parameters were unchanged among TEMPOL treated and control groups.
Our study shows that superoxide radicals participate in haemodynamic control, but acute superoxide scavenging is ineffective in
glomerular and tubular improvement, probably due to hypertension-induced strong endothelial dysfunction which neutralizes




Acute kidney injury (AKI), commonly caused by an obstruc-
tion of renal blood flow (renal ischemia) and characterized by
a rapid decline in glomerular filtration rate (GFR) [1], is fre-
quently associated with significant morbidity and mortality,
the latter in the range of 30–60%, depending on the clinical
setting and presence or absence of nonrenal organ failure
[2]. Unfortunately, therapeutic approaches to prevent or treat
ARF are extremely limited, as the majority of interventional
trials in AKI have failed in humans [3, 4]. Therefore, the
search for novel therapeutic modalities to prevent or treat
AKI represents an area of intense investigation.
There are several factors involved in the initiation and
maintenance of the AKI: decrease of glomerular capillary
permeability, backleak of glomerular filtrate, tubular obstruc-
tion, and intrarenal vasoconstriction [1], but their causal-
ity has never been selective or rarely preventable. On the
other hand, long-lasting hypertension damages medium-size
and small-size renal blood vessels, disables adequate tubu-
loglomerular responses, and predisposes nephroangioscle-
rosis patients to AKI [5]. Also, patients with preexisting
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hypertension are at a particular risk of fatal outcome during
AKI [6, 7].
Oxidative stress appears as a main mechanism causing
tissue ischemia-reperfusion injury. Reperfusion injury gen-
erates a significant amount of free reactive oxygen species
(ROS), the effect of which could not be “buffered” by
endothelial cells exposed to ischemia [8]. Many studies have
shown that ROS could induce lipid peroxidation, increase
plasma membrane permeability [9], modulate both enzyme
and membrane pump activity [10], and induce damage of
DNA molecule [11, 12]. Study of Paller [13] has shown that
antioxidants, including allopurinol, exert protective effects on
postischemic kidney in rats, dogs, mice, rabbits, and pigs.
On the other hand, study of Scaduto et al. [14] showed that
allopurinol is ineffective in ischemic model of AKI. There
are controversies related to efficacy of other antioxidative
molecules in ischemic injury. Glutathione, normally present
in tubulocites, expresses antioxidative properties, but its con-
centration markedly drops after renal ischemia [15]. Besides,
glutathione therapy has shown opposite effects in ischemia-
reperfusion injury [16, 17].
Therefore, in the present study, by using oxidative scav-
enging therapy, we sought to determine whether superoxide
radical molecules influence haemodynamic, lipid peroxida-
tion and kidney function in spontaneously hypertensive rats
(SHR) with induced postischemic AKI.
2. Materials and Methods
Male adults SHR, 24 weeks old, weighing about 300 g, were
bred in the Institute for Medical Research, Belgrade, Serbia,
and fedwith a standard chow for laboratory rats (Veterinarski
Zavod, Subotica, Serbia).
All animal experiments were conducted in accordance
with local institutional guidelines for the care and use of
laboratory animals. The investigation also conformed to the
principles and guidelines of Conseil de l’Europe (published
in the Official Daily N. L358/1-358/6, 18 December, 1986), the
US National Institutes of Health (Guide for the Care and Use
of Laboratory Animals, NIH publication number 85-23), and
the Canadian Council on Animal Care (CCAC).
2.1. Experimental Protocol. All experiments were performed
in anaesthetized (35mg/kg b.m. sodium pentobarbital;
intraperitoneal (i.p.)) rats.
2.2. ExperimentalGroups andDesign. Hypertensionwas con-
firmed in all rats by indirect measurement on tail artery
(Narco Bio Systems Inc., Houston, TX, USA), and the
animals were divided into the following experimental groups:
sham operated rats (SHAM); rats with induced postischemic
AKI (AKI control); group AKI + TEMPOL, which received
superoxide dismutase (SOD)mimetic TEMPOL (4-hydroxy-
2,2, 6,6-tetramethylpiperidine-1-15N-oxyl; Sigma Chemical
Co., USA) during ARF induction.
AKI was induced by surgical removal of right kidney
followed by atraumatic clamp occlusion of the left renal artery
for 40 minutes. Control rats received vehicle (saline), while
AKI + TEMPOL group received SOD mimetic TEMPOL
(40mg/kg/h b.w.), in the femoral vein 5 minutes before and
175 minutes after the clamp removal. After infusion, the
wound abdominal incision was surgically closed and SHR
were placed individually into metabolic cages for 24 hours,
with free access to water and chow.
2.3. Haemodynamic Measurements 24 Hours after Reperfu-
sion. Haemodynamic parameters were measured in anaes-
thetized rats, through a femoral artery catheter (PE-50, Clay-
Adams Parsippany, NY, USA), connected to a physiologi-
cal data acquisition system (9800TCR Cardiomax III-TCR,
Columbus, OH, USA). A jugular vein was cannulated with
polyethylene tubing PE-50 for the injection of cold saline.
The left carotid artery was catheterized with PE-50 tubing
and attached to a Thermo Sensor, which was coupled to
the Cardiomax III for the determination of cardiac output
(CO). The other end of thermocouple was placed in cold
saline. Following 20min for stabilization after surgery, cold
saline (0.2mL) was supplied through the jugular vein and
mean arterial pressure (MAP), heart rate (HR), and CO were
recorded. Total peripheral vascular resistance (TPVR) was
calculated from MAP and CO (assuming that mean right
atrial pressure is zero) and expressed as mmHg min kg/mL.
After abdominal incision, left renal artery preparation
was utilized and an ultrasonic flow probe (1RB, internal
diameter = 1mm) was placed around the artery for the mea-
surement of renal blood flow (RBF), using a Transonic T106
Small Animal Flowmeter (Transonic System Inc., Ithaca,
NY, USA). Vascular resistance in renal artery (RVR) was
calculated by dividing MAP by RBF, normalized for the body
weight and expressed as mmHg ×min × kg/mL.
2.4. Biochemical Measurements 24 h after Reperfusion. After
haemodynamic studies, blood samples were taken for deter-
mination of creatinine (PCr) and urea (PU) in plasma.
Lithium-heparin (Li-heparin, Sigma, USA) was used as an
anticoagulant. 24 h urine samples were used for determina-
tion of urine creatinine (UCr) and urea (UU) concentrations
in urine. All biochemical parameters were measured using
an automatic COBAS INTEGRA 400 plus (Hoffmann-La
Roche, Germany) analyzer. Creatinine (CCr) and urea (CU)
clearances were calculated according to standard formula and
normalized to body weight. After blood samples collection,
animals were sacrificed by pentobarbital overdose injection.
Further, blood samples were centrifuged at 3000 rpm
at 4∘C for 15 minutes and erythrocytes were separated.
Hemoglobin (Hb) content was estimated by the method of
Drabkin and Austin [17]. Spectrophotometric analyses of
plasma or erythrocytes were performed in Ultrospec 3300
pro UV/Visible spectrophotometer, Amersham Biosciences
Corp., USA.
Activity of catalase (CAT) in erythrocytes was deter-
mined according to the procedure of Beutler [18] by following
the absorbance of hydrogen peroxide at 230 nm. The activity
of this enzyme was expressed as unit per gram of hemoglobin
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Figure 1: Mean arterial pressure and heart rate in experimental group 24 hours after reperfusion.
Thiobarbituric acid reactive substances (TBARS), as a
marker of lipid peroxidation, were measured by using 2-
thiobarbituric acid (2,6-dihydroxypyrimidine-2-thiol; TBA).
An extinction coefficient of 156000M-1 cm-1 was used for
calculation [19] and level of TBARS was expressed as nmol
per milliliter of plasma.
2.5.Histological Examination. For determination ofmorpho-
logical changes, the left kidney was removed immediately
after sacrificing and than prepared for light microscopy. The
renal tissue was fixed in 10% buffered formalin solution.
Later, the kidney was dehydrated in alcohol and blocked
in paraffin wax, and 5 𝜇m thick sections were sliced and
stained by periodic acid-Schiff (PAS) reaction. By light
microscopy the following parameterswere semiquantitatively
evaluated on the scale from 0 to 4 according to the degree
of lesions: intensity and spread of tubular necrosis, number
of intraluminal cast formations, swelling and vacuolization
of cells, loss of luminal membrane or brush borders, tubular
dilatation, interstitial oedema, and separation of cells from
tubular basal membrane. The severity of congestion, that is,
the accumulation of red blood cells in glomeruli, peritubular
capillaries, and intrarenal veins, was graded on a scale from
1 to 3, as described by Mandal et al. [20]. The sum of
these changes represented the histopathological score for
comparison between groups. Two independent investigators
made histological evaluations; consensus was reached by
discussion, whereas for the pathohistological score the mean
value was calculated for each group.
2.6. Statistical Analysis. The results are expressed as mean ±
SEM. For results processing, we used the single-sided Stu-
dent’s 𝑡-test for two samples of equal variance (Microsoft
Excel 2010).This test was used for comparingAKI control and
SHAM, as well as AKI + TEMPOL and AKI control groups.
𝑃 values < 0.05 were considered significant.
3. Results
3.1. Haemodynamic Measurements. Both MAP and HR were
reduced in TEMPOL treated animals in comparison to AKI
control (𝑃 < 0.001 and 𝑃 < 0.05; Figure 1). Furthermore,
TPVR was significantly decreased (𝑃 < 0.05) and CO was
significantly increased in SOD mimetic treated group versus
control (𝑃 < 0.05) (Figure 2).
AKI induction significantly reduced RBF and increased
RVR in comparison to sham operated animals. TEMPOL
infusion significantly increased RBF and reduced RVR (𝑃 <
0.05) in AKI + TEMPOL group in comparison to AKI control
(Figure 3).
3.2. Biochemical Parameters. After AKI induction plasma
creatinine was significantly increased in AKI control group as
compared to sham operated animals (𝑃 < 0.001). TEMPOL
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Figure 3: Renal blood flow and renal vascular resistance in experimental group 24 hours after reperfusion.
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Figure 4: Histopathological score in experimental group 24 hours
after reperfusion.
treatment had no influence on this glomerular filtration
marker. Also, TEMPOL infusion changed neither Pu nor
Pphos levels in postischemic SHR (Table 1). Similar relation
was observed in both clearances. AKI induction significantly
reduced CCr and CU, while TEMPOL treatment had no
influence on glomerular filtration improvement (Table 1).
Enzyme catalase activity dropped after AKI induction,
while TEMPOL treatment significantly elevated its activity
(𝑃 < 0.05) 24 hours after ischemia (Table 1).
TBARS level was significantly increased in AKI group.
TEMPOL treatment significantly reduced lipid peroxidation
(𝑃 < 0.01) (Table 1).
3.3. Histological Studies. Histological examination of the
kidney specimens obtained 24 hours after AKI revealed that
rats treatedwith TEMPOLhadminormorphological changes
in comparison to AKI control group (Figure 4).
Figure 5(a) shows the normal appearance of glomeruli,
interstitium, tubules, and blood vessels in SHAM operated
animals. Only in a few kidney specimens were observed a less
number of PAS positive casts in the tubular lumen.
The kidneys of animals with AKI showed dilatation of
certain segments of the proximal and distal tubules, with or
without loss of brush border. The most notable changes were
present in the corticomedullary zone where the broad areas
of necrosis of tubules and a large number of PAS positive
casts in the collecting ducts were observed. The intensity of
interstitial edema in this group varies from sample to sample
(Figure 5(b)).
In TEMPOL treated animals, similar damage is noticed
in comparison to kidneys of control AKI animals. Tubu-
lar dilatation is noticeable. In the corticomedullary zone,
tubular necrosis is slightly reduced and infarct fields have
similar intensity as AKI control animals. Interstitial edema is
observed. In addition, the number of tubular casts in the renal
medulla is comparable to AKI control animals (Figure 5(c)).
4. Discussion
In this study we examined the role of ROS in experimental
genetically induced hypertension during postischemic AKI
development. After AKI induction we noticed both mild
MAP and HR reduction, similar to the results of Bowmer
et al. [21] performed in the model of glycerol induced
AKI. These authors considered high uremia (plasma urea
was significantly elevated in AKI group in our study as
well) influence on autonomic nervous system (diminished
𝛼
1
adrenoreceptors sensitivity) as a cause of both MAP and
HR reduction after AKI. Many studies have shown that
superoxide radical scavenging reduces blood pressure in SHR
[22–24]. Nishiyama et al. [25] have shown reduction of
both blood pressure and TPVR due to O
2
− scavenging in
Ang II induced hypertension. In our experimental setting,
TEMPOL treatment resulted in blood pressure lowering,
followed by CO increasing and concomitant TPVR reduction
in comparison to control AKI animals. Considering these
results, it is reasonable to conclude thatO
2
− generation affects
blood pressure regulation in the presented postischemic
kidney hypertensive model.
Renal vasoconstriction is one of the major pathogenetic
mechanisms of AKI development; therefore control of
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Figure 5: (a) Normal appearance of glomeruli, interstitium, tubules, and blood vessels in SHAM operated animals. Very rare PAS positive
casts in the lumen of the tubules. (b) Massive corticomedullary tubular necrosis (solid arrow). Intensive interstitial edema. Numerous PAS
positive casts in the collecting ducts and dilatation of certain segments (dash arrow) of the proximal and distal tubules (with or without loss
of brush border) in AKI control group. (c) AKI + TEMPOL group. Noticeable tubular dilatation. Slightly reduced tubular necrosis in the
corticomedullary zone, with interstitial edema. Tubular casts in the renal medulla is comparable to AKI control animals.
the renal haemodynamic is essential for this disorder.
Schnackenberg et al. [22] have shown that TEMPOL
(12.4mg/kg t.m.) significantly reduced RVR without influ-
encing RBF in SHR. Also, study of de Richelieu [26] showed
chronic treatment with TEMPOL (1mM, 15 days) towards
effective RVR reduction in SHR. Furthermore, Li et al.
[27] suggest that TEMPOL normalizes the RBF in SHR.
Results of our study are in accordance with these studies,
indicating that ROS scavenging is beneficial in reduction of
postischemic induced renal vasoconstriction in SHR. Majid
and Kopkan [28] showed that TEMPOL increased blood flow
after angiotensin II induced oxidative stress in hypertensive
rats. It is well known that postischemic AKI induces massive
production of O
2
− radicals [29], which have important role
in human and animal hypertension [30–35]. Besides, there
is increased production of NADPH oxidase iRNA in renal
tissue of SHR, which is responsible for O
2
− generation
[35]. Cai and Harrison showed [36] that overproduction
of O
2
− is closely related to endothelial dysfunction and
vasoconstriction. Therefore, we can conclude that, in our
experimental model, both blood pressure lowering and renal




In the present study, there was a sevenfold increase of
both plasma creatinine and urea and otherwise dramatically
dropping of creatinine and urea clearance after AKI induc-
tion. The former indicates detrimental glomerular filtration
after ischemia-reperfusion injury. TEMPOL treatment did
not affect these parameters of kidney function. Chatterjee
[37] reported plasma creatinine lowering due to TEMPOL
treatment after kidney injury in Wistar rats. By our opinion,
discrepancies among these studies could be explained by
hypertensive postischemic milieu in SHR, which causes
strong renal endothelial dysfunction and therefore abolishes
positive effects of O
2
− scavenging 24 hours after reper-
fusion. Hyperphosphatemia frequently occurs after AKI,
due to diminished expression of tubular sodium dependent
phosphate cotransporter [38]. In our experimental model,
TEMPOL treatment did not change phosphatemia, indicat-
ing O
2
− scavenging ineffective in tubular injury ameliora-
tion. This observation was confirmed by morphologically
unchanged tubular structure in AKI + TEMPOL group, in
comparison to AKI control. There is evidence that ischemia-
reperfusion injury results in decreased erythrocyte catalase
activity [39], what is also noticed in our experimental study.
Hence, TEMPOL treatment induced twofold increasing of
CAT activity; this should diminish oxidative stress during
postischemic AKI development in our study. Besides, Yuan
et al. [40] showed CAT activity positively correlated with
elevated antioxidant superoxide dismutase enzyme. Another
study [41] showed CAT mimetic property of TEMPOL. On
the other hand, lipid peroxidation is closely related to cell
structure damage.There were many studies showing elevated
lipid peroxidation in plasma, erythrocytes, and kidney tissue,
after renal ischemia [13, 42, 43]. TEMPOL treatment in
our hypertensive rats decreased plasma lipid peroxidation
which correlates with results of Zhang et al. [44]. They
showed TEMPOL (10mg/kg and 30mg/kg b.w.) effective
in TBARS lowering at Sprague-Dawley Ang II hypertensive
rats. Considering that NAD(P)H oxidase is one of the main
sources generating ROS [45] and that superoxide scavenging
in our study resulted in bothCAT activity increasing and lipid
peroxidation decreasing, we could be free to conclude that
TEMPOL treatment probably diminished activity of NADPH
oxidase as well. Our results show that morphological changes
in the kidney of TEMPOL treated animals were similar to
control AKI rats. Although some data [37] showed TEMPOL
treatment successful against postischemic kidney injury in
normotensive conditions, our results indicate that hyperten-
sive milieu in the kidneys of SHR suppresses morphological
renal recovery after superoxide radical scavenging.
Taken together, results of our study show that acute
TEMPOL treatment can diminish hypertension and improve
systemic haemodynamic parameters after postischemic renal
injury, suggesting that postischemic induced superoxide
anions at least in one part participate in blood pressure
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and haemodynamic control in this condition. On the other
hand, presented results indicate that acute superoxide scav-
enging is ineffective in general kidney function improvement,
despite renal haemodynamic improvement 24 hours after
reperfusion. In our opinion, this is due to strong renal en-
dothelial dysfunction induced by hypertension, which neu-
tralizes beneficial effect of acute O
2
− scavenging. Thus, tu-
bular injuries as main targets of postischemic episode remain
mostly unaffected. Beyond this disappointment, there is a
fact that TEMPOL treatment did not additionally decline
glomerular function in postischemic SHR, so it could be
effective in blood pressure therapy in hypertensive AKI
patients. On the other hand, there are many open questions
related to efficacy of long lasting TEMPOL treatment after
postischemic kidney injury in hypertension or to protective
influence of superoxide scavenging in recovery phase of AKI
which could be topic for more complex studies.
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[39] M. Inal, M. Altinişik, and M. D. Bilgin, “The effect of quercetin
on renal ischemia and reperfusion injury in the rat,” Cell
Biochemistry and Function, vol. 20, no. 4, pp. 291–296, 2002.
[40] Y. V. Yuan, D. D. Kitts, and D. V. Godin, “Heart and red
blood cell antioxidant status and plasma lipid levels in the
spontaneously hypertensive and normotensive Wistar-Kyoto
rat,” Canadian Journal of Physiology and Pharmacology, vol. 74,
no. 3, pp. 290–297, 1996.
[41] M. C. Krishna, A. Samuni, J. Taira, S. Goldstein, J. B. Mitchell,
andA. Russo, “Stimulation by nitroxides of catalase-like activity
of hemeproteins. Kinetics and mechanism,” The Journal of
Biological Chemistry, vol. 271, no. 42, pp. 26018–26025, 1996.
[42] R. Campos, M. H. M. Shimizu, R. A. Volpini et al., “N-
acetylcysteine prevents pulmonary edema and acute kidney
injury in rats with sepsis submitted to mechanical ventilation,”
The American Journal of Physiology—Lung Cellular and Molec-
ular Physiology, vol. 302, no. 7, pp. L640–L650, 2012.
[43] L. Lucchi, S. Bergamini, A. Iannone et al., “Erythrocyte suscep-
tibility to oxidative stress in chronic renal failure patients under
different substitutive treatments,” Artificial Organs, vol. 29, no.
1, pp. 67–72, 2005.
[44] G. X. Zhang, S. Kimura, A. Nishiyama, T. Shokoji, M. Rahman,
and Y. Abe, “ROS during the acute phase of Ang II hypertension
participates in cardiovascular MAPK activation but not vaso-
constriction,” Hypertension, vol. 43, no. 1, pp. 117–124, 2004.
[45] T.M. Paravicini and R.M. Touyz, “Redox signaling in hyperten-
sion,” Cardiovascular Research, vol. 71, no. 2, pp. 247–258, 2006.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
